Back

Staging and prognostic markers

13 May 2024 (16:12 - 16:24)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis: when translational approaches and personalised medicine become reality Cardiomyopathies HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Daniela Tomasoni

Spedali Civili, University Of Brescia, Brescia (Italy)

3 More presentations in this session

Presentation thumbnail
Pathophysiology and epidemiology
Professor T. Damy (Creteil, FR)
Slides Video
Presentation thumbnail
New therapeutic opportunities: from mechanisms to clinical practice
Professor M. Fontana (London, GB)
Slides Video
Presentation thumbnail
Cardiac amyloidosis: when translational approaches and personalised medicine become reality - discussion
Video

Access the full session

Session thumbnail
Cardiac amyloidosis: when translational approaches and personalised medicine become reality
Video

The Event

Event poster

Heart Failure 2024

13 May 2024 16:12 CET
You may be interested in
thumbnail
Congress Presentation
Staging classification of transthyretin cardiac amyloidosis based on the extent of cardiac damage at echocardiography: a large multicentric Registry.
thumbnail
Congress Presentation
Insights on the value of biomarkers in the management of transthyretin amyloid cardiomyopathy (ATTR-CM)
thumbnail
Congress Session
Evolving landscape in transthyretin amyloid cardiomyopathy (ATTR-CM): clinical practice and emerging treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources